About Careers Internship MedBlog Contact us
Medindia LOGIN REGISTER
Advertisement

HIV Testing Among High-Risk Men Increased Due to Facebook Intervention

by Kathy Jones on September 3, 2013 at 9:00 PM
 HIV Testing Among High-Risk Men Increased Due to Facebook Intervention

New research indicates that peer-led Facebook groups are an acceptable and effective tool for increasing home-based HIV testing among at-risk populations.

Advertisement

HIV infection is a major health concern for men who have sex with men (MSM), especially among African Americans and Latinos who have high rates of incident cases and new diagnoses. Online social networking has grown exponentially in this population, suggesting that social media platforms could be used to relay HIV prevention messages. This is important because those who seek sex online may be at increased risk for HIV. Sixteen peer leaders were randomly assigned to deliver information about HIV (intervention, n = 57) or general health (control, n = 55) via closed Facebook groups to Los Angeles-based MSM, more than 85 percent of whom were African American or Latino. After accepting a request to join the group, participation was voluntary and all online interactions were monitored to assess participation and engagement. Throughout the trial, participants in either group could request a free, home-based HIV testing kit. Participation in messaging was high in both groups throughout the trial. After 12 weeks, more intervention participants had requested an HIV testing kit than control participants (44 percent vs 20 percent, respectively). In both groups, the median number of sexual partners decreased during the trial.

Note: For an embargoed PDF, please contact Megan Hanks or Angela Collom. Lead author Dr. Sean Young can be contacted directly at sdyoung@mednet.ucla.edu.
2. Task Force: Not enough evidence to recommend for or against screening for peripheral artery disease in asymptomatic adults

Advertisement
The United States Preventive Services Task Force (USPSTF) found insufficient evidence to recommend for or against using the ankle-brachial index (ABI) as a screening test for peripheral artery disease (PAD) in asymptomatic adults. PAD is a common circulatory problem in which narrowed arteries reduce blood flow to the limbs. In addition to morbidity directly caused by PAD, patients have an increased risk for cardiovascular disease (CVD) events. Screening asymptomatic patients could reduce patient morbidity and mortality by identifying patients who are at hidden risk for CVD. The ABI is the ratio of the ankle and brachial systolic blood pressure that has been used as a marker for PAD. In 2005, the Task Force recommended against using ABI as a screening test for PAD because there was little evidence that screening would improve outcomes any more than treatment based on standard CVD risk assessment. To inform the update, researchers assessed new evidence on the ability of the ABI to predict cardiovascular disease morbidity and mortality independent of the Framingham Risk Score (FRS) in asymptomatic adults. They also assessed the benefits and harms of treating adults found to have PAD through screening. The researchers found insufficient evidence to assess the balance of benefits and harms of screening for PAD and CVD risk assessment with ABI. They also found insufficient evidence to establish the benefits of treating screening-detected PAD in asymptomatic individuals.

Note: For an embargoed PDF, please contact Megan Hanks or Angela Collom. For an interview with an author, please contact Ana Fullmer at ana.fullmer@edelman.com or 202-350-6668.
3. Methylprednisolone injections significantly improve carpel tunnel symptoms, but surgery still likely

Methylprednisolone injections significantly reduce pain and improve function in carpal tunnel syndrome (CTS) in the short term, but only slightly reduce the rate of surgery after one year. CTS is a common condition in which there is excessive pressure on the nerve in the wrist that allows feeling and movement to parts of the hand. Patients are initially treated with wrist splinting, but many go on to have surgery. While surgery often produces good outcomes, recovery can last several weeks and includes lost work time. Thus, finding an effective nonsurgical treatment is desirable. The majority of hand surgeons report using steroid injections to alleviate CTS symptoms and prevent surgery, but evidence of long-term benefit is lacking. Researchers sought to determine the efficacy of local methylprednisolone injections in CTS. Three groups of 37 patients each who had CTS but no previous steroid injections were randomly assigned to receive either 80 mg of methylprednisolone, 40 mg of methylprednisolone, or placebo. At 10 weeks, patients in the 80 mg group reported the most improvement in CTS symptom severity scores. At one year, patients who received 80 mg of methylprednisolone had a lower likelihood of having surgery than those receiving 40 mg or placebo. However, three out of four patients in the trial had surgery within one year. Time from injection to surgery was longer for the 80 mg group than 40 mg or placebo.

Note: For an embargoed PDF, please contact Megan Hanks or Angela Collom. Lead study author Dr. Isam Atroshi can be contacted directly at Isam.Atroshi@skane.se.

Source: Eurekalert
Font : A-A+

Advertisement

Advertisement
Advertisement

Recommended Readings

Latest AIDS/HIV News

HIV Vaccine Clinical Trial Initiates in the United States and South Africa
The Phase 1 trial for a preventive HIV vaccine candidate has initiated enrollment in both the United States and South Africa.
Beauty Salon-Driven Initiative Boosts PrEP Awareness in Fight Against AIDS
In the United States, African American women make up only 26% of female PrEP users, yet they account for 57% of new infections among women.
Immune-Evading HIV Protein Complex Solved
Scientists have made a groundbreaking discovery in the fight against HIV/AIDS with the successful resolution of the enigmatic immune-evading HIV protein complex.
Does Gender Influence Comorbidity Rates in HIV-Positive Smokers
Tailored quit-smoking programs are designed to address the risks associated with comorbidity in individuals living with HIV.
Digital Test Measures HIV Viral Load
DNA editing tool CRISPR-Cas13 helps diagnose and signal the presence of HIV antibodies in HIV patients.
View All
This site uses cookies to deliver our services.By using our site, you acknowledge that you have read and understand our Cookie Policy, Privacy Policy, and our Terms of Use  Ok, Got it. Close
MediBotMediBot
Greetings! How can I assist you?MediBot
×

HIV Testing Among High-Risk Men Increased Due to Facebook Intervention Personalised Printable Document (PDF)

Please complete this form and we'll send you a personalised information that is requested

You may use this for your own reference or forward it to your friends.

Please use the information prudently. If you are not a medical doctor please remember to consult your healthcare provider as this information is not a substitute for professional advice.

Name *

Email Address *

Country *

Areas of Interests